摘要:OBJECTIVE:To pro vide reference for promoting the standardized construction of centralized intravenous drug dispensing mode and the healthy development of PIVAS and improving the rational infusion in China. METHODS :The establishment and development process of PIVAS in China were reviewed ,the necessity ,current situation and problems to be solved of centralized intravenous drug dispensing mode were analyzed. RESULTS & CONCLUSIONS :Due to scientific , advanced,smooth,convenient operation procedure and standardized management ,and reduced occupation exposure ,centralized intravenous drug dispensing mode ,of which the pharmacists were in charge ,had become the inevitable development direction of intravenous drug dispensing in Chinese hospitals. The overall PIVAS construction in China had worked well and played a significant role,not only significantly improved the quality of finished infusion ,promoted rational drug use ,protected the health of nurses and ward (area) environment,but also contributed to the construction and development of the nursing profession ,and also contributed to the improvement of the pharmacy department ’s own management level. However ,the value of PIVAS pharmacist service still needs to be understood.
摘要:OBJECTIVE:To provide reference for increasing t he export trade of Guangdong ’s pharmaceutical manufacturing industry,and improving the proportion of pharmaceutical manufacturing export and internationalization level. METHODS :The data of the pharmaceutical manufacturing industry in Guangdong province were collected from 1998 to 2019,and vector autoregressive (VAR)model was established. The relationship of export trade activities (export delivery value ),R&D investment (R&D internal expenditure) and technological innovation (technological transformation cost ) of pharmaceutical manufacturing industry in Guangdong province were explored empirically through cointegration relationship test ,Granger causality test ,impulse response function and variance decomposition. RESULTS & CONCLUSIONS :Through the cointegration relationship test and Granger causality test ,it could be seen that there was a stable equilibrium relationship among the export trade activities of Guangdong pharmaceutical manufacturing industry ,R&D investment and technological innovation. Technological innovation was the Granger cause of export delivery value and could positively promotes the increase in export trade activities ,with a lag period of 2 years. The export delivery value was the Granger reason for R&D investment ,which could promote the increase of R&D investment ,and the influence will become greater and greater over time. R&D investment is the Granger cause of technological innovation ,which can promotes the increase of technological innovation. Through impulse response function and variance decomposition ,it could be known that the export trade activities ,R&D investment and technological innovation of Guangdong ’s pharmaceutical manufacturing industry had a dynamic interaction relationship. The change in export delivery value is mainly affected by itself ,and technological innovation is an auxiliary promotion effect (contribution rate of 7%). It is suggested that enterprises should pay attention to technological transformation and R&D investment ,build high-tech pharmaceutical manufacturing industry ,give full play to the characteristics of Lingnan traditional Chinese medicine products , enhance the technological competitiveness of export pharmaceutical products ,optimize the layout of pharmaceutical industry ,and enhance international competitiveness.
摘要:OBJECTIVE:To provide reference for improving the mechanism of drug supervision in Guangdong-Hong Kong-Macao Greater Bay Area. METHODS :Based on the evolutionary game theory ,the stakeholders of Guangdong-Hong Kong-Macao Greater Bay Area in the stage of drug safety supervision were identified ;the evolutionary game model was established so as to obtain the behavioral selection and evolutionary stability strategy of the each party through and put forward the suggestions for improving the mechanism of drug supervision in Guangdong-Hong Kong-Macao Greater Bay Area. RESULTS & CONCLUSIONS:Based on evolutionary game theory ,the three-party evolutionary game model of drug administration ,drug inspection and manufacturing enterprises was established. According to the model established in this study ,it could be concluded that:when the compliance cost of the production enterprise was less than the sum of the violation cost and the bribery cost minus the additional income ,or less than the sum of violation cost and punishment and reputation lossminus the additional income ,the manufacturing enterprises could achieve the equilibrium state of compliance production ;the supervision probability was inversely proportional to the supervision cost ,and strict inspection was inversely proportional to inspection cost ;compliance productivity rate and strict detection rate were in direct proportion to the intensity of supervision and penalties ;the higher the supervision probability was,the higher the strict detection rate was ,and the compliance productivity would gradually increase. It is proposed to link enterprise information files ,lay the foundation of four party cogovernance ;introduce the “cost-benefit”supervision system ,make reasonable use of the third-party inspection institutions ;clarify the boundary of personnel responsibility ,and use the intelligent system for real-time supervision so as to promote the improvement of drug safety supervision in Guangdong-Hong Kong-Macao Greater Ba y Area.
WANG Yuexin,MIAO Yulu,WANG Mei,LI Ning,WU Yingru,ZHANG Wenzhi,FENG Min,NI Yan
Vol. 32, Issue 6, (2021)
摘要:OBJECTIVE:To e stablish and compare HPLC fingerprints of green Forsythia suspensa and grown F. suspensa ,and to conduct cluster analysis and principle component analysis. METHODS :HPLC method was adopted. The determination was performed on Hypersil C 18 column with mobile phase consisted of acetonitrile- 0.1% formic acid (gradient elution ). The detection wavelength was 235 nm and column temperature was 25 ℃ with the flow rate of 1.0 mL/min. The sample size was 10 μL. HPLC fingerprints of 8 batches of green F. suspensa (Q1-Q8)and 6 batches of grown F. suspensa (L1-L6)were drawn ,with phillyrin as reference;the similarity evaluation was conducted by using Similarity Evaluation System of TCM Chromatographic Fingerprint (2012 edition),and common peak was confirmed. Cluster analysis and principal component analysis were carried out with SPSS 23.0 software. RESULTS :There were 19 common peaks for green F. suspensa and grown F. suspensa ,among which 6 peaks were identified,i.e. forsythoside A ,rutin,pinoresinol-β-D-glucoside,phillyrin,quercetin and phillygenin ;the similarities of HPLC fingerprints from green F. suspensa and grown F. suspensa were 0.351-0.767;results of cluster analysis showed that green F. suspensa and grown F. suspensa were classified into 4 categories,among which L 1-L6 were clustered into one category ,Q1 was clustered into one category ,Q2-Q6 were clustered into one category ;Q7-Q8 were clustered into one category. The results of principal component analysis showed that the cumulative variance contribution rate of the first three principal components was 83.14%, L1-L6 distribution was close ,Q2-Q6 distribution was close ,Q7-Q8 distribution was close ,and Q 1 distribution was independent , which was consistent with the results of cluster analysis. CONCLUSIONS :There were significant differences in the common peaks of fingerprint of green F. suspensa and grown F. suspensa of similarity eraluation ,cluster analysis and principle component analysis,the established HPLC fingerprint can be used for comprehensive evaluation and quality comparison of green F. suspensa and grown F. suspensa .
XING Shuyan,FAN Shanshan,YU Qinhui,MA Qingyun,SUN Qihui,YANG Yong,RONG Rong
Vol. 32, Issue 6, (2021)
摘要:OBJECTIVE:To study the effects of Mahuang xixin fuzi decoction on Toll-like receptors (TLRs)response and cytochrome C oxidase (Cyt-CO)-mediated apoptosis regulation in mice with influenza disease of kidney-yang deficiency. METHODS:Totally 48 male Balb/c mice were randomly divided into normal group (n=12)and modeling group (n=36). The modeling group was intraperitoneally injected with estradiol benzoate solution (8 mg/kg)and intranasally injected with influenza virus H 1N1(20 μL/mice)to establish the influenza disease compound model of kidney-yang deficiency. After modeling ,the mice were randomly divided into model group ,positive drug group (Oseltamivir phosphate capsules ,0.195 g/kg),Mahuang xixin fuzi decoction group (1.802 g/kg,by crude dru g),with 12 mice in each group. Each group was given relevant medicine intragastrically,normal group and model group were given, corresponding volume of normal saline intragastrically 20 mL/kg,once a day ,for consecutive 6 days. During admi-nistration,body weight and anal temperature of mice were mail:xsy407861520@163.com measured daily ;the percentage of initial body weight was calculated. After last medication ,the organ (spleen,thymus and lung )indexes were calculated ;the pathological changes of lung tissue were observed. The viral load of influenza A virus H 1N1 in lung tissue was detected (reflected by M gene mRNA expression);mRNA expressions of TLR3,TLR7,myeloid differentiation factor (MyD88)and Caspase- 3 in cardiac tissue as well as the activity of Cyt-CO and the content of cytochrome C (Cyt-C)were also determined. RESULTS :Compared with normal group,initial body weight percentage and anal temperature of the model group continued to decrease (P<0.05);the spleen and thymus indexes were decreased significantly (P<0.05),while lung index was increased significantly (P<0.05);the lung tissue lesions were serious. Viral load in lung tissue ,mRNA expressions of TLR 3,TLR7,MyD88 and Caspase- 3 in cardiac tissue as well as the content of Cyt-C were increased significantly (P<0.05 or P<0.01),while the activity of Cyt-CO in cardiac tissue was significantly decreased (P<0.01). Compared with model group ,initial body weight percentage and anal temperature of mice in Mahuang xixin fuzi decoction group showed an increasing trend from the fourth day of administration (P<0.05 or P<0.01). The spleen and thymus indexes were increased significantly (P<0.05),while the lung index was significantly decreased (P<0.05);the pathological injury of lung tissue was significantly improved ;viral load in lung tissue ,mRNA expressions of TLR 3 and Caspase- 3 as well as the content of Cyt-C in cardiac tissue were decreased significantly (P<0.05 or P<0.01),while the activity of Cyt-CO was increased significantly in cardiac tissue (P<0.01). CONCLUSIONS :Mahuang xixin fuzi decoction can improve influenza disease of kidney-yang deficiency in mice ,the effect may related to inhibit TLRs response and apoptosis regulation pathway mediated by Cyt-CO.
摘要:OBJECTIVE:To analyze the metabolites of tetrahydroxystilbene glucoside (THSG)and speculate its metabolism pathway in rats. METHODS :Male SD rats were randomly divided into plasma group (n=3),urine group (n=3),bile group (n=3),and tissue group (n=9). Each group was given single dose of THSG 200 mg/kg intragastrically. Plasma samples 10,30 min and 1,1.5,2,4 h after medication ,the unrine 0-6 h after medication ,the bile 0-4 h after medication ,the tissue of heart , liver,spleen,lung,kidney and stomach 30 min and 1,2 h after medication (3 at each time point )were collected respectively.After precipitated with methanol ,the metabolites of samples were analyzed and identified by UHPLC-Q-Exactive Orbitrap MS and mass loss filtration (MDF). Its metabolism pathway was speculated. RESULTS:In the blood ,urine,bile,heart,liver,spleen, lung,kidney,stomach samples ,6,7,11,1,5,1,3,4,4 metabolites were detected ,including two phase Ⅰ(hydrolysis, hydrogenation and hydroxylation )metabolites,18 phase Ⅱ(glucuronic acid binding and sulfation )metabolites. There were 12 glucuronic acid binding products. CONCLUSIONS:Most of the metabolites of THSG are found in bile ,mainly glucuronic acid binding products of phase Ⅱ metabolite THSG ; main metabolic pathways involve glucose hydrolysis , hydrogenation, hydroxylation,glucuronic acid binding and sulfation.
WANG Chongjuan,ZHOU Jinyan,WANG Chongjing,LIANG Yueqin,ZHU Yudan,WANG Xingxing,LI Zhongkun
Vol. 32, Issue 6, (2021)
摘要:OBJECTIVE:To study the effect s of Bifidobacterium combined with L-carnitine on intestinal flora of dysbacteriosis diarrhea model rats. METHODS :Totally 30 SD rats were randomly divided into blank control group ,model group ,probiotics group(Bifidobacterium triple viable enteric coated capsules 70 mg/mL),L-carnitine group (L-carnitine injection 50 mg/mL)and L-carnitine+probiotics group (L-carnitine injection 50 mg/mL+Bifidobacterium triple viable enteric coated capsules 70 mg/mL). Except for blank control group ,the rats in other groups were given 50 mg/mL clindamycin phosphate intragastrically (2 mL/rat, once a day ,for 4 consecutive days )to establish the model of dysbacteriosis diarrhea. On the 5th day of the experiment ,the rats in administration groups were given corresponding drugs intragastrically ,blank control group and model group were given equal volume of normal saline intragastrically ;with the dosage volume of 1 mL/rat,once a day ,for consecutive 7 days. The general situation of rats in each group was observed during the experiment. The feces of normal control group and model group at the end of the modeling and the feces of the rats in administration group after the last administration were collected for genomic DNA extraction,polymerase chain reaction amplification ,library construction and high-throughput sequencing. After processing ,the effective data were analyzed by operational taxonomic unitsclustering and species annotation ,as well as Alpha and Beta diversity of compared with blank control group ,grade 1 feces and grade 2feces were found in model group. The diversity and richness of intestinal flora ,the ratio of Firmicutes/Bacteroidetes and zhongjuanwang7@163.com the abundance of probiotics such as Lactobacillus, Bifidobacterium and Ackermann were significantly decreased (P<0.05),while the abundance of pathogenic bacteria such as Enterococcus was significantly increased (P<0.05). At the end of the recovery period ,compared with model group ,the activity,fecal morphology and color of rats in probiotics group ,L-carnitine group and L-carnitine+probiotics group returned to normal,and the diversity and richness of intestinal flora had no significant difference (P>0.05). However ,the abundance of Lactobacillus in intestinal tract was increased to a certain extent ,and the abundance of Ackermann in intestinal tract of rats in L-carnitine+probiotics group was significantly increased (P<0.05). CONCLUSIONS :Although Bifidobacterium combined with L-carnitine have no significant effect on improving the diversity and richness of intestinal flora in dysbacteriosis diarrhea model rats,it could increase the abundance of probiotics to a certain extent.
摘要:OBJECTIVE:To study the effects of Modified liuwei dihuang decoction on kidney/bone injury of chronic kidney disease-mineral and bone disorder(CKD-MBD)model rats. METHODS :The male SD rats were randomly divided into normal group(n=10),high phosphorus group (n=30),model group (n=30),calcitriol group (positive control ,0.09 μg/kg,n=30), Modified liuwei dihuang decoction group (10 g/kg by crude drug ,n=30). CKD-MBD model was established by high phosphorus and adenine diet for 6 weeks. After modeling ,normal group and model group were given normal diet/high phosphorus diet and intragastric administration of water. Administration groups were fed with normal diet and given corresponding solution intragastrically(water as solvent ),0.1 mL/kg,once a day ,for consecutive 6 weeks. Blood sample of rats in the normal group were collected ,and they were sacrificed after the last administration. Blood sample of 10 rats in each other group were collected , and they were sacrificed at 2,4 and 6 weeks after administration. The contents of blood urea nitrogen (BUN),serum creatinine (Scr),calcium,phosphorus,iPTH,FGF-23,RANKL and osteocalcin in serum were detected in each group. The bone mineral density(BMD)of femoral was measured ,the morphological changes of renal tissue and bone tissue were observed ,and the percentage of renal tubular injury and the score of renal interstitial fibrosis were calculated. RESULTS :Compared with normal group,above indexes in high phosphorus group had no significant change at different time points (P>0.05). There was no abnormal change in renal/bone tissue. Compared with high phosphorus group at the same time point ,the contents of BUN ,Scr, phosphorus,iPTH,FGF-23,RANKL and osteocalcin in serum ,the percentage of renal tubular injury and the score of renal interstitial fibrosis in the model group were significantly increased ,while the contents of calcium in serum and the BMD of femoral were significantly decreased (P<0.05 or P<0.01). The renal tissue showed diffuse fibrosis. The width of trabecular bone was increased and the number of osteoblasts was decreased. Compared with the model group at the same time point ,the contents of BUN(except for Modified liuwei dihuang decoction group after 2 weeks of administration ),Scr,serum phosphorus ,iPTH, FGF-23,RANKL and osteocalcin ,the percentage of renal tubular injury and the score of renal interstitial fibrosis in Modified liuwei dihuang decoction group and calcitriol group were decreased significantly at each time point ;serum calcium content and BMD(except for 2 weeks of administration )were significantly increased (P<0.05 or P<0.01),and the pathological changes of renal/bone tissue were significantly improved ;there was no statistical significance in above indexes between Modified liuwei dihuang decoction group and calcitriol group (P>0.05). CONCLUSIONS :Modified liuwei dihuang decoction can improve kidney/ bone injury of CKD-MBD model rats ,and improve BMD and regulate disorder of calcium and phosphorus metabolism.
摘要:OBJECTIVE:To stu dy the effect of psoralen on osteoporosis in postmenopausal rats and PI3K/Akt/mTOR signaling pathway. METHODS :Totally 60 healthy female SD rats were randomly divided into normal group ,model group ,positive control group(0.09 mg/kg estradiol ),psoralen low-dose ,medium-dose and high-dose groups (22,44,88 mg/kg),with 10 rats in each group. Except for normal group ,the other groups were ovariectomized to establish Postmenopausal osteoporosis model. After 2 months of normal feeding after operation ,normal group and model group were given the constant volume of normal saline intragastrically,and administration groups were given the corresponding solution intragastrically ;the volume was 0.005 mL/g, once a day ,for consecutive 98 days. 24 h after last administration ,the BMD of femur and vertebra of right lower extremities in rats was determined. The contents of serum calcium ,osteocalcin and P1NP,the serum levels of BMP2 and VEGF were determined;mRNA and protein expression of PI3K,Akt and mTOR in femur tissue were detected.RESULTS :Compared with normal group ,BMD of femur and vertebra ,serum contents of calcium ,osteocalcin,P1NP and serum levels of BMP 2,VEGF in model group were decreased significantly ,while the mRNA and protein expression of PI 3K,Akt and mTOR were increased significantly (P<0.05 or P<0.01). Compared with model group ,BMD of femur and vertebra ,serum levels of calcium , osteocalcin,P1NP and serum levels of BMP2(except for psoralen medium-dose group ),VEGF(except for psoralen medium-dose group)were increased significantly in psoralen medium-dose and high-dose groups ,positive control group ,while the mRNA expression(except for psoralen low-dose group )and protein expression of PI 3K,Akt and mTOR in administration groups were decreased significantly (P<0.05 or P<0.01);BMD of femur ,serum levels of calcium ,BMP2 and PI 3K protein expression in psoralen high-dose group were significantly higher than positive control group (P<0.05),and mTOR mRNA expression in psoralen high-dose group was significantly lower than positive control group (P<0.05). CONCLUSIONS :Psoralen can improve osteoporosis in postmenopausal rats ,the mechanism of which may b e associated with inhibiting PI 3K/Akt/mTOR signaling pathway.
摘要:OBJECTIVE:To study the improvement effect and mechanism of MEBO on lipopolysaccharide (LPS)-induced injury of rat skin fibroblasts. METHODS :Skin fibroblasts of rats were divided into control group ,LPS group (5 μg/mL), Kangfuxin solution group (positive control ,5 μg/mL LPS+1.25% Kangfuxin solution )and MEBO group (5 μg/mL LPS+0.6 mg/mL MEBO),with 6 wells in each group. Inflammatory injury cell model was induced by LPS (except for control group ). After a certain period of cultivation ,the cell survival rate and cell migration rate were detected in each group. The contents of TNF-α and IL-6 in cell supernatant was detected. The localization and fluorescence intensity of IL- 6 protein were detected. The protein expression of PTEN ,p-p65,TNF-α,IL-6,PI3K and Akt in the fibroblasts were also determined. RESULTS :Compared with control group ,survival rate of the fibroblasts was increased significantly in LPS group ,while cell migration was decreased significantly;the contents of TNF-α and IL-6 in cell supernatant as well as relative protein expression of PTEN ,p-p65,TNF-α, IL-6 and PI 3K were increased significantly (P<0.05 or P<0.01);IL-6 protein mainly expressed in the cytoplasm ,and the fluorescence intensity was enhanced. Compared with LPS group ,survival rate of the fibroblasts was decreased significantly in Kangfuxin solution group and MEBO group ,while migration rate was increased significantly ;the contents of TNF-α and IL-6, relative protein expression of PTEN ,p-p65,TNF-α,IL-6(except for Kangfuxin solution group ),PI3K and Akt (except for Kangfuxin solution group ) were decreased significantly (P<0.05 or P<0.01),while fluorescence intensity of IL- 6 protein decreased;relative protein expression of TNF-α,IL-6,PI3K and Akt in MEBO group were significantly lower than Kangfuxin solution group (P<0.05 or P<0.01). CONCLUSIONS :MEBO can inhibit the proliferation of LPS-induced skin fibroblasts , reduce the level of inflammatory factors and the intensity of inflammatory reaction , which may be related to the jiang- down-regulation of PTEN/NF-κB,PI3K/Akt signaling pathway.
摘要:OBJECTIVE:To establish a method for the simultaneous determination of euphol and euphorbol in Euphorbium resinifera,and to optimize the extraction technology. METHODS :HPLC method was adopted. The determination was performed on Agilent ZORBAX Eclipse Plus C 8 column with mobile phase consisted of acetonitrile-water (90∶10,V/V)at the flow rate of 1.0 mL/min. The detection wavelength was set at 210 nm,and column temperature was 30 ℃. The sample size was 10 μL. Using the contents of euphol and euphorbol ,yield of the extract as evaluation index ,comprehensive score was conducted. The extraction technology was optimized by L (9 34)orthogonal tests ,with ethanol volume fraction ,extraction time and solvent dosage as factors. RESULTS:The linear ranges of euphol and euphorbol were 0.030 4-1.216 mg/mL(r=0.999 6)and 0.01-0.4 mg/mL(r=0.999 9), respectively. RSDs of precision ,stability(24 h)and producibility tests were all lower than 2%. Average recoveries were 100.46% (RSD=1.03%,n=6)and 99.36%(RSD=0.91%,n=6). The optimized technology was extracting with 40 mL 95% ethanol for 1 h. After 3 times of validation tests showed that average content of euphol was 94.43 mg/g(RSD=0.92%,n=3),and that of euphorbol was 25.42 mg/g(RSD=0.98%,n=3);average yield of the extract was 51.42%(RSD=1.95%,n=3),and average comprehensive score was 98.87(RSD=0.92%,n=3). CONCLUSIONS :Established method is simple ,accurate and reproducible , which can be used for the quality control of E. resinifera . The optimized extraction technology is simple and stable.
摘要:OBJECTIVE:To s ystematically review the economics of osimertinib for advanced non-small cell lung cancer (NSCLC),and to provide the reference for clinical application and healthcare decision makers. METHODS :Retrieved from PubMed,Embase,the Cochrane L ibrary,Health Technology Assessment ,CNKI,Wanfang database ,VIP,CBM,etc., pharmacoeconomic studies on osimertinib in the treatment of advanced NSCLC were collected from the inception to Apr. 2020. After screening and extracting relevant data ,the quality of the included studies was evaluated by using the Quality of Health Economics Studies (QHES),and the economic research results of the included literatures were systematically evaluated by using descriptive analysis method. RESULTS & CONCLUSIONS :A total of 10 studies from 7 different countries were included ;QHES scores of the included literatures were 73-93,with an average of 86.8,and the quality of the researches was generally high. All the 10 studies were cost-effectiveness analysis ,including 6 first-line treatment ,4 second-line treatment. Six studies reported the cost discount rate ;only one study used the cost of osimertinib after price reduction for evaluation and analysis. Compared with other epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI),six studies from different countries showed that osimertinib as the first-line treatment drug had no cost-effectiveness advantage ;cost-effectiveness of second-line treatment of osimertinib was controversial ,compared to chemotherapy. For advanced NSCLC patients ,the second-line treatment of osimertinib after the national centralized negotiation of price reduction has a more cost-effectiveness advantage in China ’s medical service system,while the first-line treatment of osimertinib before price reduction does not have this advantage compared with other EGFR-TKI drugs.
关键词:Osimertinib;Advanced non-small cell lung cancers;Cost-effectiveness analysis;Systematic re view
摘要:OBJECTIVE:To study the efficacy and safety of sacubitril valsartan sodium tablets combined with Bailing capsules in the treatment of chronic left heart failure with renal insufficiency ,and to provide reference for clinical drug use. METHODS : Totally 96 patients with chronic left heart failure with renal insufficiency who sought medical care in our hospital from Nov. 2018 to Nov. 2019 were divided into group A ,B and C according to table of random numbers ,with 32 cases in each group. Group A received conventional heart failure treatment and and Bailing capsules (2 g each time ,3 times a day );group B received conventional heart failure treatment and Sacubitril valsartan sodium tablets (50 mg each time ,twice a day );group C was given with heart failure treatment and Sacubitril valsartan sodium tablets (50 mg each time ,twice a day )and Bailing capsules (2 g each time,3 times a day ). 3 groups received consecutive 6 months of treatment. Clinical response rates of 3 groups were compared. Left heart function indexes [left ventricular end systolic diameter (LVESD),left ventricular end-diastolic diameter (LVEDD),left ventricular ejection fraction (LVEF)] and serological indexes [interleukin 1(IL-1),IL-6,N terminal brain natriuretic peptide precursor,glomerular filtration rate (GFR)] were detected before and after treatment. The occurrence of ADR were observed and recorded. RESULTS :During this study ,a total of 6 patients fell off ,and eventually 90 patients completed the study ,including 29 cases in group A ,30 cases in group B and 31 cases in group C. Before treatment ,there was no statistical significance in left heart function indexes or serological indexes among 3 groups(P> 0.05). After 6 months of treatment ,clinical response rate of group C was significantly higher than those of group A and B 163.com (P<0.05). Compared with before treatment , LVEDD, LVESD and serological indexes of 3 groups were decreased significantly after treatment (P<0.05),while LVEF and GFR were increased significantly (P<0.05);the changes of above indexes (except for IL- 1 level in serum ) in group C were significantly better than group A and B ,the changes of above indexes in group B (except for GFR )were significantly better than group A (P<0.05). No significant ADR were observed in 3 groups. CONCLUSIONS :Sacubitril valsartan sodium tablets combined with Bailing capsules can significantly decrease the level of serum inflammation factors ,and improve cardiac and renal function in patients with chronic left heart failure with renal insufficiency ,with good safety.
摘要:OBJECTIVE:To study the effects o f CYP2C9*3 gene polymorphism on therapeutic efficacy of benzbromarone in lowering uric acid and its hepatotoxicity. METHODS :A retrospective study was conducted to analyze the relevant clinical indicators and genotypes of 196 gout patients who received benzbromarone and CYP2C9*3 gene polymorphism test in Wuhan third hospital from Jan. 2018 to Sept. 2019. RESULTS :Among 196 patients,179,15 and 2 patients with CYP2C9*3 genotypes * 1/*1, *1/*3 and * 3/*3 genotypes were found ,respectively,and the distribution of each genotype was in line with Hardy-Weinberg balance(P>0.05). Before treatment ,there were no significant differences in the levels of UA ,Scr,ALT,AST and CRP between *1/*1 genotype and * 1/*3+*3/*3 genotype(P>0.05). After 4 weeks of treatment ,the UA ,Scr,CRP levels of patients with * 1/*1 genotype as well as the UA and CRP levels of patients with * 1/*3+*3/*3 genotype were significantly reduced ,the UA level of patients with * 1/*1 genotype was significantly lower than that of patients with * 1/*3+*3/*3 genotype(P<0.05 or P<0.01). The ALT and AST levels had no obvious changes in patients with different genotype before and after treatment ,and they were in the normal range. No serious abnormal liver function was observed during the treatment. CONCLUSIONS :Therapeutic efficacy of benzbromarone in lowering uric acid in gout patients with CYP2C9*3 genotypes * 1/*1 genotype is better than that of * 1/*3 and * 3/*3 genotypes. However ,the gene polymorphism may be not associated with its hepatotoxicity.
摘要:OBJECTIVE:To investigate the ru les and characteristics of pembrolizumab-induced immune-related myocarditis , and to provide reference for rational drug use in clinic. METHODS :Using“pembrolizumab/keytruda”“myocarditis”“cardiotoxicity” “Pembrolizumab/Keytruda”“Cardiac toxicity ”“Myocarditis”“Cardiotoxity”“Cardiotoxicity”as Chinese and English retrieval words , CBM,VIP,CNKI,Wanfang database ,PubMed,Wiley Online Library and Embase database were searched on the case reports of pembrolizumab-induced immune-related myocarditis during the inception to Aug. 2020. After eliminating the suspected case literature and repetitive literature ,gender,age,medication cause ,medical history ,drug combination ,drug dosage ,occurrence time of ADR ,clinical manifestation ,intervention measure and outcome of patients in the included literature were analyzed. RESULTS & CONCLUSIONS:A total of 15 literatures were included ,involving 13 English literatures and 2 Chinese literatures. Totally 15 patients were involved ,including 12 males and 3 females,with an average age of 71.35 years. There were 4 cases of non-small cell lung cancer ,4 cases of melanoma ,2 cases of bladder cancer ,1 case of urothelial cancer ,1 case of multiple osteosarcomas,1 case of gastric cancer ,1 case of thymic cancer ,1 case of nasopharyngeal carcinoma. There were 6 patients with previous medical history ,of which 5 had no history of heart disease and 1 had hypertension and hyperlipidemia ;there were 9 patients recorded the combined use of drugs ;the dosage and frequency of pembrolizumab were recorded in 12 patients. Immunological myocarditis of 93.3% patients occurred after the first to second cycle of pembrolizumab administration ,and the average occurrence time was 15.5 days after the last administration. The most common clinical symptoms were dyspnea ,fatigue, dizziness or syncope. 9 patients showed cardiac block on electrocardiogram. All patients were treated with glucocorticoids when they developed immune-associated myocarditis ,and 5 patients died after hospitalization ;another one patient was restarted with pembrolizumab for one cycle after control of immune-related myocarditis ,but developed a recurrence of myocarditis and died of myocarditis ADR. It is suggested that baseline examination and routine monitoring of cardiac function should be done well when patients are treated with pembrolizumab. Once the patient is su spected to have immune-related myocarditis ,they should timely improve the cardiograms and other cardiac function-relatedtests,and start the treatment of high-dose glucocorticoids as 198177) soon as possible ,and are alert to the risk of death due to recurrence of myocarditis after readministration.
摘要:OBJECTIVE:To systematically evaluate the effectiveness and safety of Shenfu qiangxin pills combined with chemical medicine conventional therapy in the treatment of chronic heart failure ,and to provide evidence-based reference for clinical drug use. METHODS :Retrieved from CNKI ,Wanfang database ,VIP,Google Scholar ,PubMed,the Cochrane Library and Embase database ,RCTs about Shengfu qiangxin pills combined with chemical medicine conventional therapy (trial group ) versus chemical medicine conventional treatment (control group )were collected during the inception to May 12th,2020. After literature screening and data extraction ,the quality of the literatures was evaluated with risk bias assessment tool recommended by Cochrane 5.1.0 system evaluator manual. Meta-analysis and sensitivity analysis were performed by using Stata 14.0 software. RESULTS:A total of 7 RCTs were included ,involving 596 patients. Meta-analysis results showed that the total response rate of trial group was significantly higher than that of control group [OR =4.14,95%CI(2.15,7.97),P<0.000 01];the results of sub-group analysis according to the different criteria for determining the efficacy showed that the total response rates of trial group determined by Lee integral method and cardiac function grading method were sig nificantly higher than that of the control group (P<0.05). After treatment ,N-terminal pro-B-type natriuretic peptide (NT-proBNP) level of trial group was significantly lower than that of control group [OR =-1.33,95%CI(-1.55, qq.com -1.11),P<0.000 01]. Results of sub-group analysis accor- ding to cardiac failure type showed that NT-proBNP level of patients with chronic heart failure in trial group was lower than control group (P<0.001). The level of left ventricular ejection fraction (LVEF)in trial group after treatment [WMD =5.76,95%CI (5.05,6.47),P<0.000 01] was significantly higher than control group ;after treatment ,the level of B-type natriuretic peptide [SMD=-1.61,95%CI(-2.58,-0.54),P<0.000 01],left ventricular end-diastolic diameter (LVEDD)level [WMD = -6.06,95%CI(-6.84,-5.27),P<0.000 01],left ventricular end-systolic diameter level [WMD =-0.52,95%CI(-5.70,-4.33), P<0.000 01] were significantly lower than control group. There was no statistically significant difference in the incidence of ADR between 2 groups(P>0.05). Results of sensitivity analysis showed that when NT-proBNP ,LVEF level ,LVEDD level after treatment were used as indicators ,there was no significant difference in the analysis results after eliminating heterogeneity source , compared with before elimination. CONCLUSIONS :Shenfu qiangxin pills combined with chemical medicine conventional treatment has good efficacy and safety.
摘要:OBJECTIVE:To systematically evaluate the effectiveness and safety of Compound danshen dripping pills in improving aspirin resistance ,and to provide evidence-based evidence for clinical drug use. METHODS :Retrieved from CNKI , VIP,Wanfang database ,CBM,PubMed,Embase,the Cochrane L ibrary,randomized controlled trials (RCTs)about Compound danshen dripping pills (trial group )versus aspirin (control group )were collected during the inception to Jun. 2020. After literature screening and data extraction ,bias risk assessment tool recommended by the Cochrane evaluation manual handbook 5.1.0 was used to evaluate the quality of the included literatures ,and Rev Man 5.3 software was used for Meta-analysis and publication bias analysis. RESULTS :A total of 10 RCTs were included ,with a total of 800 patients. Meta-analysis showed that the platelet aggregation rate (PAR)induced by adenosine diphosphate (ADP)in trial group was significantly lower than that of control group [SMD =-2.63,95%CI(-3.56,-1.70),P<0.000 01]. Results of sub-group analysis by treatment cycle showed that PAR induced by ADP in trial group after 2 weeks of treatment [SMD =-2.11,95%CI(-2.75,-1.46),P<0.000 01],4 weeks of treatment [SMD =-2.84,95%CI(-4.26,-1.41),P<0.000 1] Δ 基金项目 :国家重点研发计划中医药现代化研究重点专项 and 8 weeks of treatment [SMD =-2.63,95%CI(-3.21, (No.2019YFC1710000,No.2019YFC1710003);国家中医药管理局中 - 2.04),P<0.000 01] was significantly lower than control 医药循证能力建设项目(No.2019XZZX-XXG003);河南省创新型科技 团队项目 group. PAR induced by arachidonic acid (AA)of trial group *硕士研究生 。研究方向:中西医结合心血管疾病的预防和治 was significantly lower than that of control group [SMD = 疗。E-mail:guohongxin1214@163.com -2.44,95%CI(-3.64,-1.24),P<0.000 1]. Results of # 通信作者:主任医师,教授,硕士生导师,博士。研究方向:中医 sub-group analysis by treatment cycle showed that PAR 药防治心血管疾病的临床和基础 。电话:0371-66233478。E-mail: induced by AA in trial group after 2 weeks of tre atment [SMD = zhumingjun317@163.com -2.56,95%CI(-3.26,-1.85),P<0.000 01],4 weeks of 中国药房 2021年第32卷第6期 China Pharmacy 2021Vol. 32 No. 6 ·743· treatment of [SMD =-2.45,95%CI(-4.79,-0.10),P=0.04],8 weeks of treatment [SMD =-2.38,95%CI(-2.94,-1.82),P< 0.000 01] was significantly lower than control group. The decrease of ADP-induced PAR [SMD =2.24,95%CI(1.36,3.13),P< 0.000 01],AA-induced PAR [SMD =2.42,95%CI(1.94,2.89),P<0.000 01] and response rate [RR =8.56,95%CI(4.38,16.74), P<0.000 01] in trial group were significantly higher than control group ,while the incidence of ADR [RR =0.30,95%CI(0.15, 0.60),P=0.000 6],the incidence of ischemic events [RR =0.13,95%CI(0.07,0.27),P<0.000 01],CR and RF after treatment (P<0.05)were significantly lower than control group. There was no statistical significant difference in the incidence of bleeding events between 2 groups [RR =0.78,95% CI(0.34,1.78),P=0.55]. The results of publication bias showed that there was less possibility of publication bias in this study. CONCLUSIONS :Compound danshen dripping pills can effectively improve aspirin resistance and has good safety.
摘要:OBJECTIVE:To systematically evaluate the therapeutic efficacy and safety of Chinese patent medicine compound preparation combined with conventional therapy for psoriasis vulgaris ,and to provide evidence-based reference for clinical drug use. METHODS :Retrieved from CNKI ,Wanfang database ,VIP,CBM,PubMed,the Cochrane Library and Web of Science , RCTs about Chinese patent medicine compound preparation combined with conventional therapy versus conventional therapy in the treatment of psoriasis vulgaris were collected during the inception to Feb. 2020. After literature retrieval and data extraction ,the quality of the included studies was evaluated with risk bias assessment tool recommended by the Cochrane evaluation manual handbook 5.1. Bayesian network Meta-analysis was perfor med by using Stata 15.0 software,Addis 1.16.6 software and Markov Chain Monte Carlo method. RESULTS :A total of 41 RCTs were included ,involving 4 122 patients. 5 kinds of interven- tion measures included Compound qingdai capsule ,Xiaoyin SF-010) granule, Keyin pill ,Yujin yinxie tablet and conventional therapy. Results of network Meta-analysis showed that in terms of improving the total effective rate , compared with conventional therapy ,4 kinds of Chinese patent medicine compound preparations combined with conventional therapy could significantly improve the total effective rate (P<0.05);the results of network Meta-analysis were as follows :Keyin pill combined with conventional therapy >Compound qingdai capsule combined with conventional therapy >Xiaoyin granule combined with conventional therapy >Yujin yinxie tablet combined with conventional therapy >conventional therapy. In terms of reducing psoriasis area and severity index (PASI)score after treatment ,compared with conventional therapy ,Keyin pill and Xiaoyin granule combined with conventional therapy could significantly reduce the PASI score (P<0.05),while Compound qingdai capsule and Yujin yinxie tablet combined with conventional treatment had no significant difference (P>0.05);the results of network Meta-analysis showed that Xiaoyin granule combined with conventional therapy >Keyin pill combined with conventional therapy > Compound qingdai capsule combined with conventional therapy >Yujin yinxie tablet combined with conventional therapy > conventional therapy. In terms of reducing serum inflammatory factor level ,compared with conventional therapy ,Compound qingdai capsule and Xiaoyin granule combined with conventional therapy could significantly reduce the level of IL- 17(P<0.05), but Keyin pill and Yujin yinxie tablet combined with conventional therapy had no significant difference (P>0.05);the results of network Meta-analysis showed that Xiaoyin granule combined with conventional therapy >Compound qingdai capsule combined with conventional therapy >Yujin yinxie tablet combined with conventional therapy >Keyin pill combined with conventional therapy>conventional therapy. In terms of safety ,there was no statistical significance in the incidence of ADR between 4 kinds of Chinese patent medicine combined with conventional therapy and conventional therapy (P>0.05);the results of network Meta-analysis showed that Compound qingdai capsule combined with conventional therapy >Xiaoyin granule combined with conventional therapy >Keyin pill combined with conventional therapy >conventional therapy >Yujin yinxie tablet combined with conventional therapy . CONCLUSIONS :Compared with conventional therapy ,additional use of 4 kinds of Chinese patent medicine compound preparations can improve the curative effect of psoriasis vulgaris patients with blood heat syndrome ,and Keyin pill is the best ;Xiaoyin granule is the best in reducing the degree of skin lesions and serum inflammatory factors ;additional use of 4 kinds of Chinese patent medicine compound preparations show good safety ,and Compound qingdai capsule is the best.
摘要:OBJECTIVE:To establish the eva luation criteria for the rationality of tumor nutritional standardized treatment ,and to provide reference for nutritional standardized treatment in tumer patients . METHODS :Based on domestic and foreign guidelines or expert consensus ,the rationality evaluation standard of tumor nutritional standardized treatmentwas formulated in our hospital (Bozhou Municipal People ’s Hospital ). 50 nutritional treatment medical records in our hospital from Jan. to Jun. 2019 were evaluated by weighted TOPSIS ;according to the evaluation results ,nutritional intervention was carried out ,and 50 nutritional treatment medical records (group B )from Aug. to Dec. 2019 were re-evaluated by the same method after intervention. RESULTS : The established evaluation criteria for the rationality of tumor nutritional standardized treatment in our hospital included 18 indicators,such as malnutrition diagnosis ,description of the nature of malnutrition ,nutrition screening and evaluation ,etc. After analysis ,the rational rate of nutritional treatment was only 18% in group A (Ci of ideal solution with 9 medical records≥0.6),and 78% in group B (Ci of ideal solution with59 medical records ≥0.6). There was statistical significance in the rationality of nutritional treatment before and after nutritional intervention (Ci≥0.6)(P<0.05). CONCLUSIONS :The established rational evaluation method of tumor nutritional standardized treatment is feasible ,and the evaluation results are intuitive and reasonable. Nutrition intervention is helpful to reduce the irrational rate of nutritional treatment.
关键词:Weighted TOPSIS method;Tumor;Nutritional standardized treatment;Evaluation criteria;Rational clinical use